159 related articles for article (PubMed ID: 20955617)
1. Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer.
Won HS; Lee MA; Chung ES; Kim DG; You YK; Hong TH; Lee IS
BMC Cancer; 2010 Oct; 10():564. PubMed ID: 20955617
[TBL] [Abstract][Full Text] [Related]
2. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
[TBL] [Abstract][Full Text] [Related]
5. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma.
Park KW; Jung ES; Kim DG; Yoo YK; Hong TH; Lee IS; Koh YH; Kim JH; Lee MA
Cancer Res Treat; 2013 Mar; 45(1):63-9. PubMed ID: 23613672
[TBL] [Abstract][Full Text] [Related]
6. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
Jarnagin WR; Klimstra DS; Hezel M; Gonen M; Fong Y; Roggin K; Cymes K; DeMatteo RP; D'Angelica M; Blumgart LH; Singh B
J Clin Oncol; 2006 Mar; 24(7):1152-60. PubMed ID: 16505435
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
Teh M; Wee A; Raju GC
Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.
Kim K; Kim DH; Chae SW; Shin JH; Kim HJ; Do SI; Lee HJ; Koo JH; Pyo JS; Sohn JH
Pathol Oncol Res; 2014 Apr; 20(2):409-15. PubMed ID: 24178677
[TBL] [Abstract][Full Text] [Related]
9. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.
Nagakawa T; Kayahara M; Ikeda S; Futakawa S; Kakita A; Kawarada H; Matsuno M; Takada T; Takasaki K; Tanimura H; Tashiro S; Yamaoka Y
J Hepatobiliary Pancreat Surg; 2002; 9(5):569-75. PubMed ID: 12541042
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of survivin expression in gallbladder carcinoma.
Salman T; Argon A; Kebat T; Vardar E; Erkan N; Alacacıoğlu A
APMIS; 2016 Aug; 124(8):633-8. PubMed ID: 27214404
[TBL] [Abstract][Full Text] [Related]
13. Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase.
Harino Y; Imura S; Kanemura H; Morine Y; Fujii M; Ikegami T; Uehara H; Shimada M
Int J Clin Oncol; 2008 Oct; 13(5):452-7. PubMed ID: 18946757
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
15. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
17. Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma.
Yamaguchi R; Nagino M; Oda K; Kamiya J; Uesaka K; Nimura Y
Br J Surg; 2002 Sep; 89(9):1130-6. PubMed ID: 12190678
[TBL] [Abstract][Full Text] [Related]
18. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
19. Neural cell adhesion molecule and perineural invasion in gallbladder cancer.
Seki H; Koyama K; Tanaka J; Sato Y; Umezawa A
J Surg Oncol; 1995 Feb; 58(2):97-100. PubMed ID: 7844990
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Mizutani M; Hirai I
Hepatogastroenterology; 2007 Sep; 54(78):1635-40. PubMed ID: 18019682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
